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Abstract
Purpose Different protocols are being used worldwide for the
cryopreservation of human ovarian tissue for fertility preser-
vation purposes. The efficiency and efficacy of the majority of
these protocols has not been extensively evaluated, possibly
resulting in sub-optimally cryopreserved ovarian tissue. To
address the impact of this issue, we assessed the effects of
two clinically successful human ovarian tissue slow-freezing
cryopreservation procedures on the quality of the cryopre-
served tissue.
Methods To differentiate between cryopreservation (C) versus
thawing (T) related effects, four combinations of these two (A
and B) very different cryopreservation/thawing protocols
(ACAT, ACBT, BCAT, BCBT) were studied. Before and after
cryopreservation and thawing, the percentage of living and
morphologically normal follicles, as well as the overall tissue
viability, was assessed.
Results Our experiments revealed that the choice of the cryo-
preservation protocol noticeably affected the overall tissue
viability and percentage of living follicles, with a higher via-
bility after protocol BC when compared to AC. No statistically
significant differences in tissue viability were observed be-
tween the two thawing protocols, but thawing protocol BT
required considerably more human effort and materials than
thawing protocol AT. Tissue morphology was best retained
using the BCAT combination.
Conclusion Our results indicate that extensive and systematical
evaluation of clinically used protocols is warranted.
Keywords Ovarian tissue . Cryopreservation . Fertility
preservation . Efficiency . Efficacy
Introduction
The survival of pediatric, adolescent, and young adult cancer
patients has significantly improved during the past decades
[1]. As a consequence, the attention to issues related to quality
of life after cancer has increased in oncological care. With
many types of oncological therapy posing a threat to the ovar-
ian function [2], techniques aimed at preserving fertility in
girls and young women have emerged and evolved [3]. In this
paper, we focus on the cryopreservation of ovarian tissue. In
prepubertal girls, and in women who cannot delay the start of
chemotherapy, this is the only available option for fertility
preservation [4, 5]. The ovarian tissue is obtained before start
of the gonadotoxic anti-cancer therapy and can be
autotransplanted to the patient after she has been cured of
her disease, to restore her fertility. In three major European
centers for fertility preservation, a pregnancy rate of 27 % was
reported after autotransplantation of ovarian tissue, and more
than 60 babies have been born worldwide [5–7].
The freezing/thawing protocol used for cryopreservation of
the ovarian tissue is most likely to be an important factor in
determining the clinical outcome (i.e., live birth) of ovarian tissue
autotransplantation. Several laboratory procedures that have led
to the birth of healthy children have been published [8–17].
CapsuleOur results indicate that extensive and systematical evaluation of
clinically used protocols is warranted.
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The mere fact that children were born using a certain
protocol, however, does not automatically imply that this
protocol had been optimized to its maximum potential. In
other words, tweaking the protocol might have led to an
even higher success rate. To address this matter, we com-
pared the impact of two clinically successful, but method-
ologically very different freezing and thawing laboratory
procedures on the quality of the cryopreserved tissue. To
determine the contribution of the freezing and the thawing
procedure on the human ovarian tissue quality, we ana-
lyzed the effects of these events separately.
Materials and methods
Study design and eligibility criteria
The effects of the two selected cryopreservation and thawing
protocols: protocol ACAT using ethylene glycol as cryoprotec-
tant [18, 19] and BCBT using DMSO as cryoprotectant [13,
20, 21] on overall ovarian tissue’s viability, follicle viability,
and tissuemorphologywere investigated in a four-arm design:
– ACAT: cryopreservation and thawing protocol A
– BCBT: cryopreservation and thawing protocol B
– ACBT: cryopreservation protocol A followed by thawing
protocol B
– BCAT: cryopreservation protocol B followed by thawing
protocol A
For ethical reasons, we could not use tissue from young
cancer patients applying for ovarian tissue cryopreservation.
We therefore used ovarian tissue from premenopausal wom-
en aged ≤45 years who were considered eligible for this
prospective cohort study if they underwent a prophylactic
laparoscopic salpingo-oophorectomy at the Radboud univer-
sity medical center (Radboudumc), Nijmegen, the
Netherlands. Informed consent was obtained prior to sur-
gery. When possible, cortex tissue from each patient was
included in all four arms of the study. In addition, a fresh
(positive) control was analyzed for each patient before cryo-
preservation/thawing. In case of insufficient material (due to
size of the ovary, presence of large follicles, and/or extensive
damage as a result of cauterization during surgery), the cor-
tex tissue of a given patient was only used in three or less of
the study arm protocols.
Ethical approval
All study procedures were approved by the Radboudumc local
ethics committee.
Ovarian tissue preparation
At the operating theater, the ovary dissected during surgery
was collected in cold Custodiol (4 °C; Dr. Franz Köhler
Chemie GmbH, Bensheim, Germany). The ovary was imme-
diately transferred to the laboratory (within 5–10 min), where
it was placed on a pre-cooled surface (0 °C). The medulla was
removed from the cortex using precision forceps and scalpels,
after which ovarian cortex fragments of approximately 5 mm
in length, 5 mm in width, and 1.0–1.5 mm in depth were
prepared. These 5 × 5 × 1 mm fragments were subsequently
used to prepare 3-mm-diameter punch biopsies for the glucose
uptake assay (overall tissue viability) and for preparing small
tissue fragments for the neutral red stain (follicle viability).
Ovarian tissue cryopreservation and thawing
The ovarian tissue cryopreservation and thawing protocols
selected for this study differ considerably. Briefly, protocol
A consists of a cryopreservation protocol using ethylene gly-
col combined with a thawing protocol based on three consec-
utive short washes to remove the cryoprotectant. Protocol B
uses dimethyl sulfoxide (DMSO) as a cryoprotectant and has a
significantly longer and more elaborate thawing procedure
based on continuous dilution. Tissue was stored in liquid ni-
trogen for at least 1 week before thawing.
As we combined two clinically used protocols in our study,
we measured the osmolality of the four cryopreservation and
thawing solutions in order to determine any additional osmot-
ic stress to which the tissue was exposed when applying cryo-
preservation and thawing solutions from different protocols.
Cryopreservation protocol AC
Tissue fragments were equilibrated in 30 mL of cryomedium,
consisting of 0.1 mol/L sucrose (Sigma-Aldrich, Zwijndrecht,
the Netherlands) and 1.5 mol/L ethylene glycol (Merck
Millipore, Schiphol-Rijk, the Netherlands) in phosphate-
buffered saline (PBS; Braun, Melsungen, Germany) for
30 min on a tilting table at 4 °C. Instead of using a Planer
Freezer (Planer K10; Planer Ltd, UK), ovarian cortical frag-
ments were frozen in Nunc CryoTubes (Sigma-Aldrich, St.
Louis, MO, USA) in 1 mL cryomedium in a CryoLogic pro-
grammable temperature controller (CL-3300, Cryosolutions,
‘s Hertogenbosch, the Netherlands) using CryogenesisTM V5
software (Cryosolutions). CryoTubes were transferred to the
CryoLogic set at 0 °C. Subsequently, the temperature was
lowered at a rate of 2 °C/min until a temperature of −9 °C
was reached. At this stage, CryoTubes were seeded manually
with a cotton swab dipped in liquid nitrogen. The temperature
remained at −9 °C for 10 min after which seeding was
checked. Next, the temperature was decreased at a rate of
0.3 °C/min to −40 °C and subsequently with 8.5 °C/min to
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−120 °C before the CryoTubes was stored in liquid nitrogen.
This freezing protocol was comparable to the original proto-
col, expect for the duration at which the temperature remained
at −9 °C (5 versus 10 min) and the speed at which the tem-
perature was lowered after reaching −40 °C (8.5 °C/min to
−120 °C versus 10 °C/min to −140 °C in the original protocol;
[18]). The cryomedium had an osmolality of 2.3 Osmol/kg.
Thawing protocol AT
Tissue was thawed rapidly at 37 °C and then rinsed in 25 mL
of three solutions (PBS containing 0.25 mol/L sucrose and
0.75 mol/L ethylene glycol; PBS containing 0.25 mol/L su-
crose; and PBS, respectively) for 10 min each under continu-
ous agitation to wash out the cryoprotectant. The first washing
solution had an osmolality of 1.5 Osmol/kg. In total, this re-
sulted in a thawing procedure of approximately 35 min.
Cryopreservation protocol BC
According to cryopreservation protocol BC [13, 20, 21], a
freezing solution with an osmolality of 2.1 Osmol/kg was
prepared consisting of Leibovitz’s L-15 GlutaMAX
cryomedium (Gibco, Carisbad, CA, USA), containing 10 %
dimethyl sulfoxide (1.4 mol/L; CryoSure-DMSO; Wak-
Chemie Medical GmbH, Steinbach, Germany), and 10 % se-
rum substitute supplement (SSS; Irvine Scientific, Santa Ana,
CA, USA). Nunc CryoTubes were filled with 1.7 mL cold
medium (0 °C) and a cortex fragment. Instead of using the
program as described for the IceCube (14S-A, SY-LAB,
Neupurkersdorf, Austria) in the original protocol [13], the
CryoTubes were frozen in the CryoLogic programmable tem-
perature controller using the program as stated under
BCryopreservation protocol AC.^ This freezing protocol was
comparable to the original protocol, expect for an incubation
step in the programmable freezer at 2 °C for 40 min, the
seeding temperature (−9 instead of −6 °C, allowing us to
freeze tissue according to protocol AC and BC simultaneously
and in the same Cryologic freezing device) and the speed at
which the temperature was lowered after reaching −40 °C
(8.5 °C/min to −120 °C versus 10 °C/min to −140 °C in the
original protocol).
Thawing protocol BT
Thawing protocol BTwas based on continuous dilution of the
cryoprotectant [20]. The CryoTubes were removed from the
liquid nitrogen, warmed for 30 s at room temperature, and
placed in a 37 °C water bath for 2 min. Directly after thawing,
the ovarian cortex fragments were transferred to a solution of
10 mL Dulbecco’s Phosphate-Buffered Saline (DPBS;
Gibco), 0.75 M sucrose (MP Biomedicals, Eschwege,
Germany), 10 % serum substitute supplement (SSS; Irvine
Scientific, Santa Ana, USA), and 0.1 mg/mL Pen/Strep
(Lonza, Basel, Switzerland) and incubated under continuous
agitation for 15 min at room temperature. This first washing
solution had an osmolality of 1.2 Osmol/kg. After this first
incubation step, 50 mL of a solution consisting of DPBS with
10 % SSS and 0.1 mg/mL Pen/Strep was added using a pump
set at 100 mL/h. At complete infusion (30 min), the cortex
fragments were transferred into a 5 mL pre-warmed (37 °C)
Hepes-buffered medium (Gamete, Cook Medical Europe
LTD, Limerick, Ireland) and incubated for another 15 min.
After repeating this step once, the tissue was washed three
times for 5 min in tissue culture medium used for the glucose
uptake assay (described below). In total, this resulted in a
thawing procedure of approximately 1.5 h.
Outcome measures
For the control as well as the four study arms, the overall
ovarian tissue viability, follicle viability, and tissue morphol-
ogy were examined using the following methods.
Glucose uptake assay
The ovarian tissue’s overall viability was assessed using a
glucose uptake assay we described previously [22]. This assay
quantitatively measures the glucose uptake by ovarian tissue
during in vitro culture. Glucose uptake has been shown to be
inversely correlated with the extent of (cryo)damage the tissue
has sustained [22]. This assay has also been successfully used
for determining the viability of human ovarian cortex tissue
after cryopreservation [21].
For each individual measurement, four cortex biopsies
were prepared using a 3-mm-diameter biopsy punch (Pfm
Medical ag, Cologne, Germany). For each of these four ovar-
ian biopsies, glucose uptake was determined by culturing
them separately in 2 mL Dulbecco’s Modified Eagle
Medium High Glucose (4.5 g/L) with L-Glutamine (DMEM,
PAA Laboratories) supplemented with 10% fetal bovine se-
rum (FBS; PAA Laboratories GmbH, Cölbe, Germany) and
0.1 % Pen/Strep (GIBCO; 10.000 units penicillin/mL and
10.000 μg streptomycin/mL) in a 24-well plate (TPP,
Trasadingen, Switzerland) at 37 °C in humidified air with
5 % CO2. The 2 mL of conditioned culture medium was col-
lected from each individual biopsy, and replaced by fresh me-
dium at day 4 and again collected at day 7, when the culture
was ended. After culture, the biopsies were weighed separate-
ly and the glucose content of unconditioned medium (control)
and of the conditioned medium after 4 or 7 days of culture
were measured using an Architect i2000 system (Abbott
Diagnostics, IL, USA). The glucose uptake of each biopsy
during the culture period from day 0–4 and day 4–7 was
determined by subtracting the glucose content of the condi-
tioned medium from the unconditioned control medium.
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Glucose uptake was corrected for the weight (mg) of the bi-
opsy and the duration (h) of the culture period [21, 22]. Then,
for each series of four biopsies cultured under the same con-
ditions, the mean glucose uptake/milligram/hour (nmol) was
calculated representing an individual measurement on day 0–
4, day 4–7, and (combined) day 0 to 7.
Percentage of living follicles
The viability of ovarian follicles was assessed in fresh tissue,
or immediately after thawing, using a neutral red (NR) assay
modified from Kristensen et al. [23]. With this metabolic as-
say, based on the ability of living cells to incorporate and bind
neutral red in their lysosomes [24], living follicles were
stained red, whereas dead follicles remained transparent
(Fig. 1). A total of 10–15 fragments (<1 mm3) were cut from
3–4 ovarian cortex fragments of 5 × 5 × 1 mm, and incubated
in 5 mL Ultraculture (Lonza) supplemented with 1 mg/mL
Collagenase type IA (Sigma-Aldrich, Steinheim, Germany)
at 37 °C for 1 h to soften and partially dissolve the tissue.
Subsequently, the suspension was centrifuged at 400×g for
5 min after which the tissue pellet was resuspended in NR
solution, consisting of 4.8 mL McCoy medium (Gibco, Life
Technologies, New York, USA), 75 μL neutral red (to a final
concentration of 50 mg/mL; Sigma-Aldrich), 2 μL Albuman
(200 g/L; Sanquin, Amsterdam, the Netherlands), 50 μL
Insulin-Transferrin-Selenium (ITS-G, Gibco), 200 units peni-
cillin (Gibco), and 200 μg streptomycin (Gibco). The NR
suspension containing the ovarian tissue was incubated for
90 min at 37 °C in humidified air with 5 % CO2. Next, the
partly dissolved tissue fragments were removed from the bot-
tom of the tube and placed on a glass slide. By gently pressing
a cover slip on the softened tissue fragments, a squash prepa-
ration was obtained. Living (stained red) as well as dead (non-
stained) follicles were counted in this preparation using light
microscopy. The percentage of living follicles was document-
ed for each condition for which a NR viability assay was
performed, provided that at least 20 follicles could be
analyzed. Results obtained from samples with less than 20
follicles were considered unreliable and therefore excluded
from further analysis. Using these criteria, the percentage of
living follicles could be determined in the tissue of 16 patients
while the tissue of the five remaining patients was excluded.
Tissue morphology
For histology, cortex fragments of 5 × 5 × 1 mm from 18 pa-
tients were fixed in Bouin’s solution (Sigma-Aldrich) and
subsequently embedded in paraffin wax. Eight μm
hematoxylin- and eosin-stained sections were examined using
light microscopy and photographed. For each fragment, three
sections were evaluated. Sections were separated by 100 μm
of tissue to prevent counting the same pre-antral follicle twice.
Follicles were scored as morphologically normal or
degenerated (in case of cytoplasmatic shrinkage, disorganized
granulosa cells, pyknotic nuclei) and categorized as primordi-
al/primary, secondary, or antral according to a predefined
criteria [25]. We focused at the percentage of degenerated/
dead follicles rather than the total number of follicles observed
per study arm as the density of follicles in various parts of the
cortex of the same ovary may vary considerably [26].
Statistical methods
A linear-mixed model for repeated measurements was used to
study differences between protocols used for cryopreservation
and for thawing on each of variables of the viability of human
ovarian tissue, separately. In this way, it is possible to find
small within-subject differences relative to a large between-
subject (biological) variation. The dependent variable was the
glucose uptake and the percentage living follicles, respective-
ly. The independent categorical variables were cryopreserva-
tion (two protocols AC, BC), thawing (two protocols AT, BT),
and the time point of measurement (two levels day 0–4, day
4–7). The intercept of each patient was treated as a random
variable, in order to allow different levels for different
ba c
Fig. 1 Follicles visualized by neutral red staining. a Overview of living
follicles of various sizes as visualized with the neutral red viability stain.
Due to the thickness of the squash preparation, not all follicles are in
focus. b Fresh tissue with a viable follicle (red) and dead follicle
(transparent). c Close-up of a living follicle. Bars represent 200 μM
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patients. Initially, all interaction terms between the categorical
variables were included in the linear part of the model.
However, these terms were omitted from the final model pre-
sented as these did not statistically significant improve the fit
to the data (Likelihood-Ratio test). The estimated mean differ-
ences between the levels of each variable with the appropriate
95 % confidence interval are presented. Statistical analyses
were performed by using SAS® version 9.2 for Windows
(SAS institute Inc. Cary, NC, USA).
Results
Patient characteristics
A total of 21 women (median age 40 years; range 32–45)
participated in this study. Twenty women were healthy
BRCA 1 or 2 mutation carriers who did not receive prior
gonadotoxic therapy, whereas one woman had her ovaries
removed because of breast cancer after chemotherapy. Ten
women used contraceptives (oral, n = 5; intrauterine device,
n = 4; NuvaRing, n = 1), 10 had regular menstrual cycles,
and one had had a hysterectomy in the past. This last par-
ticipant was considered premenopausal as she had a normal
level of anti-Mϋllerian hormone (AMH 3.2 μg/L) without
menopausal symptoms. For four women, only part of the
study arms could be evaluated, because of a small ovary
(n = 2), the presence of large follicles (n = 1), or cauteriza-
tion damage (n = 1).
Glucose uptake
In Table 1, the observed median glucose uptake per milligram
ovarian tissue per hour of culture is presented for fresh ovarian
tissue, and for ovarian tissue subjected to one of the four
different combinations of freezing (AC and BC) and thawing
protocols (AT and BT), expressed as mean of 4 separately
assayed cortex fragments per individual patient (n = 18–21;
see Table 1). Biopsies showed no difference in weight be-
tween cultured biopsies and fresh biopsies (data not shown).
Glucose uptake was comparable for the day 0–4 culture
and the 4–7 day culture period and was not significantly dif-
ferent (Tables 1 and 2). For reasons of clarity, only the day 0–4
results are described.
As expected, the highest glucose uptake was found for
fresh tissue (23.5 nmol/mg/h). Note that the range of glucose
uptake by the tissues derived from individual patients was
large (range 8.3–32.7 nmol/mg/h), demonstrating a large
inter-patient variability. Independent of the thawing protocol,
tissue cryopreserved according to protocol BC had a signifi-
cantly higher glucose uptake when compared to AC (BCBT
16.3 and BCAT 17.3 vs ACBT 7.1 and ACAT 8.7 nmol/mg/h,
Table 1). In Table 2, the estimated differences of the glucose
uptake between the cryopreservation and thawing protocols—
as obtained by a linear-mixed model for repeated measure-
ments—are presented. According to this model, tissue that
was cryopreserved using protocol BC showed a statistically
significant higher glucose uptake (6.8 nmol/mg/h higher;
p < 0.001) than tissue cryopreserved using protocol AC
(Table 2). A small difference in glucose uptake (1.7 nmol/
mg/h) was found in favor of the shorter thawing protocol A
T when compared to BT, but this difference did not reach
statistical significance (p = 0.051; Table 2).
To eliminate the large inter-patient variability in glucose
uptake mentioned previously, we also expressed glucose up-
take of frozen and thawed ovarian tissue as a percentage of the
glucose uptake by fresh control tissue (Fig. 2). As already
observed for the absolute values of glucose uptake levels in
Table 1, the decrease in glucose uptake was considerably less
in tissue frozen via the BC protocol (19.8 and 13.5 % decrease
for the BCBT and BCAT protocol, respectively), compared to
tissue frozen via the AC protocol (50.4 and 56.8 % decrease
for the ACBT and ACAT protocol, respectively). The decrease
in glucose uptake was independent of the thawing protocol.
Remarkably, we observed a post freeze/thaw increase in glu-
cose uptake in comparison to the glucose uptake by the cor-
responding fresh control tissue in small subset of patients (1–5
patients per freeze/thaw protocol combination).
Percentage of living follicles
A mean number of 80 follicles (SD 49) was evaluated in each
ovarian tissue sample using the neutral red viability assay after
having excluded samples with less than 20 follicles (n = 21 out
of n = 98). Similar numbers of follicles could be counted be-
fore and after excluding the samples with less than 20 follicles
for each of the study arms (data not shown). In Table 1, the
observed percentages of living follicles obtained with the neu-
tral red viability assay are presented. In accordance with the
results regarding the tissue’s glucose uptake, tissue that was
cryopreserved according to protocol BC showed a statistically
significant higher percentage of living follicles when com-
pared to tissue cryopreserved according to protocol AC
(p=0.002; Table 2 and Fig. 3). Analogously to the results of
the glucose uptake assay, we observed no significant differ-
ence between thawing protocols AT and BTwith respect to the
percentage of living follicles (p=0.651; Table 2).
We found the correlation between glucose uptake and fol-
licle viability to be poor in all four study arms during 0–4 and
4–7 day culture (Spearman’s correlation <0.3, p values 0.33–
0.99).
Follicle morphology
Histological examination of the hematoxylin- and eosin-stained
sections from fresh tissue revealed that 99 % of the follicles
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were morphologically normal. After cryopreservation/thawing
according to the four study arms, 89 % (ACAT), 85 % (ACBT),
93 % (BCAT), and 84 % (BCBT) of the primordial/primary
follicles were morphologically normal, whereas the remaining
primordial/primary follicles showed cytoplasm shrinkage, dis-
organized granulosa cells, or pyknotic nuclei as a sign of folli-
cle degeneration (Fig. 4). The majority of the total of 2039
follicles observed were in the primordial or primary stages.
For each of the four study arms as well as the fresh tissue, 2–
3% of the follicles were in their secondary or antral stages. The
percentage of degenerated secondary follicles was similar to the
percentage degenerated primordial/primary follicles. Most of
the follicles (>90 %) in the antral stage showed some signs of
degeneration after freezing and thawing.
Discussion
Currently, many different protocols are usedworldwide for the
cryopreservation and subsequent thawing of human ovarian
tissue intended for fertility preservation. Little is known re-
garding the relative efficiency and efficacy of these protocols.
To investigate this matter, we compared two human ovarian
tissue slow-freezing cryopreservation and thawing protocols
that have both proven to be clinically successful. Our explicit
goal was to explore any possible differences in efficiency and
efficacy between protocols that are clinically used, rather than
to identify a superior freezing/thawing protocol.
The glucose uptake by ovarian tissue derived from dif-
ferent patients showed a large degree of variability
(Table 1). This was also observed in a previous study
[21]. These differences may be explained by ovarian cor-
tex tissue heterogeneity between different patients or, al-
ternatively, reflect differences in the initial viability of the
tissues due to differing periods of warm ischemia after the
surgical removal of the ovary.
We observed significant differences between two pro-
tocols for freezing human ovarian tissue with regard to
their effect on glucose uptake. We have previously shown
that glucose uptake is strongly correlated with tissue
Table 1 The observed median (range) of the glucose uptake and the percentage of living follicles for each combination of cryopreservation protocol
and thawing protocol
Protocol Glucose uptake (nmol/mg/h) Living follicles (%)
Cryopreservation Thawing N Culture days 0–4 median (range) Culture days 4–7 median (range) N median (range)
Fresh Fresh 21 23.5 (8.3–32.7) 20.3 (8.8–28.3) 11 94.5 (89.1–98.3)
AC AT 18 8.7 (−0.5–29.5) 8.1 (1.0–26.8) 16 72.5 (26.3–95.4)
AC BT 19 7.1 (−0.5–25.3) 6.5 (−5.5–29.0) 15 76.6 (20.0–95.7)
BC AT 20 17.3 (0.8–31.3) 18.2 (0.5–30.9) 17 87.5 (65.5–96.1)
BC BT 20 16.3 (1.9–24.1) 16.8 (3.2–23.9) 14 88.7 (18.2–100.0)
The glucose uptake is expressed in nanomolars per milligram of ovarian cortex tissue per hour of culture. Follicle viability assessment by the neutral red
staining was performed in fresh tissue or immediately after thawing. The percentage of living follicles was only determined in preparations in which at
least 20 follicles could be counted
AC cryopreservation protocol A, AT thawing protocol A, BC cryopreservation protocol B, BT thawing protocol B, N number of patients
Table 2 The estimated mean
difference (95 % confidence
interval (CI)) of the glucose
uptake and the percentage of
living follicles between the
cryopreservation protocols,
thawing protocols, and culture
periods, using a linear-mixed
model for repeated measurements
Protocol/day Glucose uptake (nmol/mg/h) Living follicles (%)
Estimated difference Estimated difference
mean (95 % CI) p value mean (95 % CI) p value
Cryopreservation AC 0.0 Reference 0.0 Reference
BC 6.8 (5.0; 8.6) <0.001 11.3 (4.6; 18.0) 0.002
Thawing AT 0.0 Reference 0.0 Reference
BT −1.7 (−3.5; 0.0) 0.051 −1.5 (−8.1; 5.1) 0.651
Culture period Day 0–4 0.2 (−1.6; 1.9) 0.842
Day 4–7 0.0 Reference
AC cryopreservation protocol A, AT thawing protocol A, BC cryopreservation protocol B, BT thawing protocol B
1610 J Assist Reprod Genet (2016) 33:1605–1614
viability [21, 22]. A better tissue viability, as observed
after applying protocol BC for cryopreservation of human
ovarian tissue, may translate in improved efficacy, i.e., an
increase in the number of live births.
Several differences between cryopreservation protocols AC
and BC can be identified; the major one being the use of
ethylene glycol as a cryoprotectant in protocol AC and
DMSO in protocol BC.
Previous studies have compared DMSO and ethylene gly-
col—in the absence or presence of sucrose—in slow-freezing
protocols for the cryopreservation of animal or human ovarian
tissue or isolated follicles. In accordance with the results of the
current study, a better follicle morphology and a higher per-
centage of living follicles were found after cryopreservation
using DMSO when compared to ethylene glycol for human,
sheep, or goat ovarian tissue [27–30]. However, DMSO did
not improve the preservation of the follicle survival and ultra-
structure when compared to ethylene glycol in bovine or
agouti tissue [31, 32].
The two thawing procedures we used were very different
with respect to the composition of the thawing solutions, as
well as the length of the thawing process. This makes it diffi-
cult to separately evaluate the effects of the factor time and of
the various components used in the thawing solution and,
consequently, to pinpoint the individual contribution of these
two factors on the efficacy of the thawing procedure. The
exact reason for the effects on thawing efficacy notwithstand-
ing, it is clear that protocol AT was more time effective and
required less human effort and material than protocol BT and
can therefore be considered more efficient.
Interestingly, the percentage of morphologically normal
follicles was generally higher than the percentage of viable
follicles. This may due to the fact that follicles that appear
Fig. 2 Glucose uptake by
ovarian cortex tissue after
different combinations of
cryopreservation and thawing
protocols. Total glucose uptake
during 7 days of culture is
expressed as a percentage of
glucose uptake by fresh (=non-
frozen, non-thawed) ovarian
cortex tissue of the same patient.
Mean and 95 % confidence
interval are indicated. AC
cryopreservation protocol A, AT
thawing protocol A, BC
cryopreservation protocol B, BT
thawing protocol B
Fig. 3 Percentage of living follicles in ovarian tissue after different
combinations of cryopreservation- and thawing protocols. Follicle
viability was assessed by neutral red staining. Results are expressed as
percentage living follicles of the total number of follicles that was
counted, and expressed as mean and 95 % confidence interval
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morphologically normal are, due to the freezing and thawing
procedure, not metabolically active anymore.
We found no correlation between follicle viability and levels
of glucose uptake. This is not surprising as stromal cells con-
tribute by far the most to the cellular volume of the ovarian
cortex. As a consequence result from the glucose uptake, assay
will predominantly reflect the viability of the stromal compart-
ment. We have shown that stromal cells are more sensitive to
the damaging effects of the freeze thaw/procedure than follicles
(as demonstrated by the decrease in glucose uptake after freeze/
thawing, and the decrease in viable follicles, respectively).
Similar findings were reported by Kim et al. [33] and
Sanfilippo et al. [16]. Stromal cells are essential for the neovas-
cularization of an ovarian graft after autotransplantation [34]
and thus for follicle growth and maturation after transplanta-
tion. In this context, including viability of the stromal compart-
ment in the evaluation of cryopreservation and thawing proto-
cols, it is essential.
Several factors may have influenced the outcome of our
study. First, the donors of ovarian tissue (BRCA mutation
carriers) are considerably older than the population eligible
for cryopreservation of ovarian tissue. Several authors have
shown that the composition and structure of ovarian tissue
alters as a result of aging [35, 36]. Consequently, the effects
of various cryopreservation and thawing protocols should be
further evaluated in a population of young patients applying
for fertility preservation. Secondly, the percentage of living
follicles observed after NR stain may be overestimated as
the dead, non-stained follicles are less visible and might be
missed during analysis. Finally, our experiments included
combining a freezing solution containing DMSO and a
thawing solution with ethylene glycol. Obviously, this will
never be the combination of choice, as this will result in dif-
ferent rates of efflux and influx of two different cryoprotec-
tants into the cells. However, we decided to test these combi-
nations to study the effect of freezing and thawing separately.
Cryopreservation and thawing protocols might be modi-
fied or optimized over time. For example, human ovarian
tissue was initially cryopreserved without a protein source in
the cryopreservation medium in protocol ACAT [18]. In a
more recent overview presented by the same group, howev-
er, the otherwise identical cryopreservation medium was de-
scribed to contain 1 % serum albumin [19]. The impact of
this change in protocol was not evaluated by the team using
the protocol in clinical practice and it is therefore unknown
to what extent this modification would have changed the
results of our current study. Obviously, it remains unknown
from our data to what extent the impairment of the ovarian
tissue viability observed in this study influences pregnancy
rates after autotransplantation.
a c
d e
b
Fig. 4 Follicle morphology after
different combinations of
cryopreservation and thawing
protocols. Follicle morphology
was determined by analysis of
hematoxylin-/eosin-stained
sections of ovarian cortex tissue
before (panel a) and after
cryopreservation and thawing
according to cryopreservation
protocol AcAT (panel b), protocol
AcBT (panel c), protocol BcBT
(panel d), and protocol BcAT
(panel e). In panels b–e, the
follicles with pyknotic nuclei
(black arrow heads) and
cytoplasmic shrinkage (white
arrow heads) are indicated. Bars
represent 100 μM
1612 J Assist Reprod Genet (2016) 33:1605–1614
In conclusion, we demonstrate considerable differences in
the effects of two clinically successful freezing and thawing
protocols on the viability of human ovarian tissue, in a series
of 21 patients. More precisely, the efficacy of the freezing
protocols and the efficiency of the thawing procedures proved
to be very different. To the best of our knowledge, this is the
first report on human ovarian tissue cryopreservation that pro-
vides information on the effectiveness of the cryopreservation
and the thawing procedures separately. Once again, we would
like to emphasize that it was not our intention to discover the
ultimate cryopreservation protocol. Rather, we want to stress
that there actually are, with regard to efficacy and efficiency,
considerable differences between clinically successful cryo-
preservation protocols. As a consequence, further optimiza-
tion of these protocols may lead to even higher success rates.
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